ES2039248T3 - Un procedimiento para preparar una forma terapeutica de acetominofen secado por pulverizacion. - Google Patents

Un procedimiento para preparar una forma terapeutica de acetominofen secado por pulverizacion.

Info

Publication number
ES2039248T3
ES2039248T3 ES87309256T ES87309256T ES2039248T3 ES 2039248 T3 ES2039248 T3 ES 2039248T3 ES 87309256 T ES87309256 T ES 87309256T ES 87309256 T ES87309256 T ES 87309256T ES 2039248 T3 ES2039248 T3 ES 2039248T3
Authority
ES
Spain
Prior art keywords
acetominofen
preparing
procedure
spray dried
therapeutic form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87309256T
Other languages
English (en)
Spanish (es)
Inventor
Robert George Blank
Dhiraj Shantilal Mody
Gary Robert Agism
Richard John Kenny
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Application granted granted Critical
Publication of ES2039248T3 publication Critical patent/ES2039248T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Glanulating (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES87309256T 1986-10-21 1987-10-20 Un procedimiento para preparar una forma terapeutica de acetominofen secado por pulverizacion. Expired - Lifetime ES2039248T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/921,556 US4767789A (en) 1986-10-21 1986-10-21 Spray dried acetaminophen

Publications (1)

Publication Number Publication Date
ES2039248T3 true ES2039248T3 (es) 1995-04-01

Family

ID=25445618

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87309256T Expired - Lifetime ES2039248T3 (es) 1986-10-21 1987-10-20 Un procedimiento para preparar una forma terapeutica de acetominofen secado por pulverizacion.

Country Status (12)

Country Link
US (1) US4767789A (de)
EP (1) EP0268383B1 (de)
JP (1) JP2550364B2 (de)
KR (1) KR950014442B1 (de)
AT (1) ATE64309T1 (de)
AU (1) AU594202B2 (de)
CA (1) CA1308662C (de)
DE (1) DE3770767D1 (de)
ES (1) ES2039248T3 (de)
GR (1) GR3002127T3 (de)
IE (1) IE61953B1 (de)
NZ (1) NZ222107A (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270056A (en) * 1985-10-25 1993-12-14 Aktiebolaget Hassle Particle having a dyed coke indicator and a pharmaceutical coating for parenteral administration of the pharmaceutical
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US4946684A (en) * 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
US5037658A (en) * 1989-09-14 1991-08-06 Hoechst-Roussel Pharmaceuticals, Inc. Direct dry compressible acetaminophen composition
US5130140A (en) * 1989-09-14 1992-07-14 Hoeschst-Roussel Pharmaceuticals Inc. Method of making direct dry compressible acetaminophen composition
US5198228A (en) * 1989-09-14 1993-03-30 Hoechst-Roussel Pharmaceuticals Inc. Direct dry compressible acetaminophen tablet
ATE118345T1 (de) * 1990-08-07 1995-03-15 Pfizer Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen.
US5562919A (en) * 1993-05-20 1996-10-08 American Meat Protein Corporation Dried animal plasma as a pharmaceutical excipient for compressed tablet formulation
AUPN940796A0 (en) * 1996-04-23 1996-05-16 F.H. Faulding & Co. Limited Taste masked pharmaceutical compositions
US5795586A (en) * 1996-08-07 1998-08-18 De Novo, Inc. Toxin decontaminant food product and method of forming same
US6294189B1 (en) 1996-08-07 2001-09-25 De Novo, Inc. Method of forming decontaminant food product
US6432442B1 (en) 1998-02-23 2002-08-13 Mcneil-Ppc, Inc. Chewable product
JP2003508420A (ja) 1999-09-02 2003-03-04 ノストラム・ファーマスーティカルズ・インコーポレイテッド 経口投与に適した、制御された放出の経口用量
US7972621B2 (en) * 2004-06-03 2011-07-05 R.P. Scherer Technologies, Llc Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
JP5026675B2 (ja) * 2005-03-08 2012-09-12 洋文 竹内 錠剤、およびその製造方法
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
US9925138B2 (en) 2015-01-20 2018-03-27 Handa Pharmaceuticals, Llc Stable solid fingolimod dosage forms
IL267689B2 (en) 2016-12-31 2025-05-01 Bioxcel Therapeutics Inc Use of sublingual dexmedetomidine for the treatment of agitation
BR112020026672A2 (pt) 2018-06-27 2021-03-30 Bioxcel Therapeutics, Inc. Formulações de filme contendo dexmedetomidina e métodos para produzi-las
BR112022000992A2 (pt) 2019-07-19 2022-06-14 Arx Llc Regimes de tratamento de dexmedetomidina não sedantes
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5420572B2 (de) * 1973-04-27 1979-07-24
JPS51118816A (en) * 1975-04-08 1976-10-19 Meiji Seika Kaisha Ltd A process for stabilizing non-crystalloidal solid
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
DE3173600D1 (en) * 1980-05-20 1986-03-13 Mallinckrodt Inc Spray dried n-acetyl-p-aminophenol compositions and method for manufacture thereof
US4439453A (en) * 1980-12-22 1984-03-27 Monsanto Company Directly compressible acetaminophen granulation
JPS58172311A (ja) * 1982-04-02 1983-10-11 Kodama Kk 持続性製剤及びその製法
US4631284A (en) * 1984-11-19 1986-12-23 Mallinckrodt, Inc. Acetaminophen compositions containing low doses of chlorpheniramine maleate, method for preparing same and tablets formed therefrom

Also Published As

Publication number Publication date
ATE64309T1 (de) 1991-06-15
KR950014442B1 (ko) 1995-11-28
US4767789A (en) 1988-08-30
DE3770767D1 (de) 1991-07-18
AU7950887A (en) 1988-04-28
GR3002127T3 (en) 1992-12-30
IE61953B1 (en) 1994-11-30
JPS63112516A (ja) 1988-05-17
NZ222107A (en) 1989-07-27
EP0268383A1 (de) 1988-05-25
EP0268383B1 (de) 1991-06-12
JP2550364B2 (ja) 1996-11-06
IE872752L (en) 1988-04-21
KR880004803A (ko) 1988-06-27
AU594202B2 (en) 1990-03-01
CA1308662C (en) 1992-10-13

Similar Documents

Publication Publication Date Title
ES2039248T3 (es) Un procedimiento para preparar una forma terapeutica de acetominofen secado por pulverizacion.
DE3783332D1 (de) Spruehgetrocknetes acetaminophen.
ES2032450T3 (es) Un procedimiento para preparar acetaminofen secado por pulverizacion.
DE3778825D1 (de) Spruehgetrocknetes acetaminophen.
SE8504720L (sv) Ny lekemedelsberedning
IT7928301A0 (it) Forme galeniche di somministrazione di medicamenti per via orale,a liberazione programmata,e loro procedimenti di preparazione
FI890508L (fi) Menetelmä farmaseuttisesti aktiivisten 3-indolipalorypälehappojohdannaisten valmistamiseksi
NO883612D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktive estere en 9-(2-hydroksyetoksymetyl)guanin.
NO860332L (no) Fremgangsmaate for fremstilling av terapeutisk aktive alfa-(2-okso-2,4,5,6,7,7a-heksahydro-tieno(3,2-c)-5-pyridyl)-fenyl-eddiksyre-derivater.
FI885460L (fi) Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi
FI871087A7 (fi) Menetelmä terapeuttisesti aktiivisten 1,2,3,4-tetrahydro-3-karbamoyyli-2-tiokso/okso-5-pyrimidiinikarboksyylihappojohdannaisten valmistamiseksi
IT1164076B (it) Composti farmaceutici ad azione antiulcera e procedimento per la loro preparazione
NO870998D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktive acetamid-derivater.
NO165545C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nye oksadiazolimidazo-benzodiazepinderivater.
IT8747635A0 (it) Derivati della purina, loro preparazione e loro impiego come medicamenti
FI900145L (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
IT8921558A0 (it) Composti organici del germanio e procedimento per la loro produzione.
NO176180C (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive 2-karbonyl-substituerte N,N-di(trimetoksybenzoyl) piperanziner
BR7401719D0 (pt) Processo para a fabricacao de imidazo 4,5-b piridinas e composicoes para o combate de helmintos parasitarios
PT84176B (pt) Processo para a preparacao de derivados de 2,6-dioxabiciclo {3.3.o7octano uteis como medicamentos
IT7923846A0 (it) Solfoniluree, processo per la loro preparazione, preparati farmaceutici a base di questi composti e loro impiego.
NO852700L (no) Fremgangsmaate for fremstilling av partikler med enhetlig stoerrelse av vannuopploeselige organiske forbindelser.
ATE57374T1 (de) N,n-dimethylethylaminoxidderivat, herstellungsverfahren und pharmazeutische mittel.
JPS5238012A (en) Vermicides for animals against acanthocephalans

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 268383

Country of ref document: ES